Current Management Strategies for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients
Authors:
- 1 March 2000
- journal article
- Published by Springer Nature in BioDrugs
- Vol. 13 (3) , 159-175
Abstract
Cytomegalovirus (CMV) infection in solid organ transplantation is associated with significant morbidity and mortality. Primary infection, secondary infection or superinfection may occur in this...Keywords
This publication has 167 references indexed in Scilit:
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Prevention of cytomegalovirus disease in transplant recipientsThe Lancet, 1995
- OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver TransplantationThe Journal of Infectious Diseases, 1995
- Cytomegalovirus infection and disease after liver transplantationDigestive Diseases and Sciences, 1992
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovirDiagnostic Microbiology and Infectious Disease, 1987
- Acquisition of Donor Strains of Cytomegalovirus by Renal-Transplant RecipientsNew England Journal of Medicine, 1986
- Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal TransplantationNew England Journal of Medicine, 1983
- Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus InfectionNew England Journal of Medicine, 1978